Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 9 studies | 30% ± 13% | |
| cardiac muscle cell | 5 studies | 35% ± 10% | |
| retinal pigment epithelial cell | 4 studies | 38% ± 12% | |
| ionocyte | 3 studies | 25% ± 5% | |
| epithelial cell | 3 studies | 36% ± 23% | |
| type I pneumocyte | 3 studies | 22% ± 5% | |
| renal principal cell | 3 studies | 30% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 3 studies | 16% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 1917.86 | 226 / 226 | 82% | 5.08 | 331 / 406 |
| prostate | 88% | 461.43 | 216 / 245 | 91% | 5.04 | 457 / 502 |
| kidney | 100% | 938.39 | 89 / 89 | 26% | 1.79 | 233 / 901 |
| lung | 92% | 305.82 | 532 / 578 | 28% | 1.05 | 321 / 1155 |
| pancreas | 85% | 106.93 | 278 / 328 | 22% | 1.13 | 40 / 178 |
| breast | 42% | 76.43 | 193 / 459 | 56% | 3.32 | 627 / 1118 |
| thymus | 74% | 112.79 | 485 / 653 | 22% | 0.87 | 131 / 605 |
| heart | 82% | 412.64 | 703 / 861 | 0% | 0 | 0 / 0 |
| muscle | 82% | 310.87 | 655 / 803 | 0% | 0 | 0 / 0 |
| ovary | 28% | 59.83 | 50 / 180 | 44% | 2.10 | 189 / 430 |
| stomach | 44% | 40.90 | 158 / 359 | 6% | 0.21 | 17 / 286 |
| intestine | 37% | 86.57 | 358 / 966 | 5% | 0.12 | 24 / 527 |
| brain | 22% | 25.59 | 589 / 2642 | 19% | 0.50 | 132 / 705 |
| uterus | 23% | 127.27 | 39 / 170 | 17% | 0.77 | 79 / 459 |
| bladder | 29% | 31.67 | 6 / 21 | 4% | 0.16 | 22 / 504 |
| esophagus | 19% | 17.60 | 270 / 1445 | 9% | 0.28 | 17 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.18 | 5 / 45 |
| skin | 2% | 2.00 | 43 / 1809 | 1% | 0.02 | 3 / 472 |
| blood vessel | 2% | 3.50 | 26 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 2% | 1.65 | 23 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 0.87 | 3 / 258 | 0% | 0 | 0 / 230 |
| peripheral blood | 1% | 0.97 | 5 / 929 | 0% | 0 | 0 / 0 |
| spleen | 0% | 1.95 | 1 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007229 | Biological process | integrin-mediated signaling pathway |
| GO_0033627 | Biological process | cell adhesion mediated by integrin |
| GO_0072659 | Biological process | protein localization to plasma membrane |
| GO_0050852 | Biological process | T cell receptor signaling pathway |
| GO_0001772 | Cellular component | immunological synapse |
| GO_0045121 | Cellular component | membrane raft |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FYB2 |
| Protein name | FYN-binding protein 2 (Activation-dependent, raft-recruited ADAP-like phosphoprotein) |
| Synonyms | C1orf168 ARAP |
| Description | FUNCTION: Adapter protein that plays a role in T-cell receptor (TCR)-mediated activation of signaling pathways. Required for T-cell activation and integrin-mediated T-cell adhesion in response to TCR stimulation . . |
| Accessions | Q5VWT5 ENST00000343433.7 [Q5VWT5-1] |
